RECITAL 40

Pays: Israël

Langue: anglais

Source: Ministry of Health

Achète-le

Notice patient Notice patient (PIL)
06-08-2017

Ingrédients actifs:

CITALOPRAM AS HYDROBROMIDE

Disponible depuis:

UNIPHARM LTD, ISRAEL

Code ATC:

N06AB04

forme pharmaceutique:

TABLETS

Composition:

CITALOPRAM AS HYDROBROMIDE 40 MG

Mode d'administration:

PER OS

Type d'ordonnance:

Required

Fabriqué par:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL

Groupe thérapeutique:

CITALOPRAM

Domaine thérapeutique:

CITALOPRAM

indications thérapeutiques:

For the treatment of states of depression or panic disorder.

Date de l'autorisation:

2011-07-31

Notice patient

                                119278010
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s prescription only
RECITAL 20 MG
RECITAL 40 MG
Tablets
Tablets
COMPOSITION:
Each RECITAL 20 tablet contains:
Citalopram (as HBr) 20 mg
Each RECITAL 40 tablet contains:
Citalopram (as HBr) 40 mg
Each RECITAL 20 tablet contains 76 mg lactose.
Each RECITAL 40 tablet contains 152 mg lactose.
For a list of the inactive ingredients, please see section 6.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE
MEDICINE. It is recommended to have a person close to you read this
leaflet. This leaflet contains concise information about the medicine.
If you have further questions, refer to the doctor or pharmacist.
This medicine has been prescribed to treat your ailment. Do not
pass it on to others. It may harm them even if it seems to you
that their medical condition is similar. This medicine is not usually
intended for use in children and adolescents below 18 years of age
(see “Special warnings regarding use of the medicine” section).
Antidepressants and anti-anxiety medicines increase the risk
of suicidal actions and thoughts in children, adolescents and
young adults up to the age of 25.
Following commencement of treatment with the medicine,
patients of all ages, as well as their relatives, should monitor
behavioral changes such as: worsening of depression, suicidal
thoughts, aggression etc.
Refer to the doctor immediately if such changes occur.
1. WHAT IS THE MEDICINE INTENDED FOR?
THERAPEUTIC ACTIVITY: For treatment of depression and anxiety
disorder.
RECITAL belongs to a group of antidepressants called selective
serotonin reuptake inhibitors (SSRI). These medicines increase
serotonin levels in the brain. Disturbances in the serotonin system
in the brain are considered an important factor in the development
of depression and related diseases.
THERAPEUTIC GROUP: selective serotonin reuptake inhibitors
(SSRI).
2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE IF:
                                
                                Lire le document complet
                                
                            

Documents dans d'autres langues

Notice patient Notice patient hébreu 06-08-2017

Rechercher des alertes liées à ce produit

Afficher l'historique des documents